“The global Single use Bioprocessing Market is projected to reach USD 18.2 billion by 2031, growing at a CAGR of 12.5% from 2024 to 2031.”
North America currently dominates the market with a 41% share in 2023. The rising demand for biopharmaceuticals, advantages of single-use technologies such as reduced contamination risk, lower capital investment, and faster setup times are key factors driving market growth.
The Single use Bioprocessing industry has seen significant advancements in recent years, with the development of more efficient and scalable single-use systems. The COVID-19 pandemic further accelerated the adoption of single-use technologies due to the urgent need for vaccine production and the benefits of rapid deployment and flexibility offered by these systems.
Growing Demand for Biopharmaceuticals
The increasing prevalence of chronic diseases and the rising demand for biologic drugs are major drivers for the Single use Bioprocessing Market.
Single-use technologies enable faster and more efficient production of biopharmaceuticals, making them an attractive option for manufacturers. In 2022, the global biopharmaceutical market was valued at USD YY billion and is expected to grow at a CAGR of 8.5% from 2023 to 2030.
Advantages of Single-use Systems
Single-use bioprocessing offers several advantages over traditional stainless-steel systems, including reduced risk of cross-contamination, lower capital investment, faster setup times, and increased flexibility. These benefits have led to the widespread adoption of single-use technologies across the biopharmaceutical industry.
A recent survey by BioPlan Associates found that 85% of biopharmaceutical manufacturers use single-use systems in at least one phase of their production process.
Technological Advancements
Continuous innovations in single-use technologies, such as the development of high-performance polymers, advanced sensors, and automated systems, are driving market growth.
These advancements improve the efficiency, reliability, and scalability of single-use bioprocessing, making it an increasingly attractive option for manufacturers. In 2021, Sartorius launched the FITBIR, a fully integrated single-use bioreactor system for the production of cell culture-based biologics.
Single-use Bioreactors Dominate the Product Segment
Single-use bioreactors are the largest product segment in the Single use Bioprocessing Market, accounting for 35% of the total market share in 2023. The growing demand for biopharmaceuticals and the advantages of single-use bioreactors, such as reduced contamination risk and increased flexibility, are driving the growth of this segment.
In 2022, Thermo Fisher Scientific introduced the HyPerforma DynaDrive Single-Use Bioreactor, which offers improved mixing and oxygen transfer capabilities for high-density cell culture processes. The global single-use bioreactor market is expected to reach USD YY billion by 2028, growing at a CAGR of 14.2% from 2023 to 2028.
North America Dominates the Single use Bioprocessing Market
North America is the largest market for single-use bioprocessing, accounting for 41% of the global market share in 2023. The presence of a well-established biopharmaceutical industry, high adoption rate of single-use technologies, and favorable government initiatives are the key factors driving market growth in this region.
In 2023, the US government announced a USD 2 billion investment in the development and manufacturing of biopharmaceuticals, with a focus on advancing single-use technologies. This initiative is expected to further boost the adoption of single-use bioprocessing in North America. The US single-use bioprocessing market was valued at USD YY billion in 2022 and is projected to reach USD YY billion by 2030, growing at a CAGR of 11.3% during the forecast period.
In 2022, Canada's National Research Council invested USD 45 million in the establishment of a new biomanufacturing facility focused on the development and production of cell and gene therapies using single-use technologies.
The Single use Bioprocessing Market is highly competitive, with several key players vying for market share. Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, and GE Healthcare are among the leading companies in the market. These companies are focusing on product innovation, strategic partnerships, and mergers & acquisitions to strengthen their market position. In 2021, Thermo Fisher Scientific acquired PPD, Inc., a leading provider of clinical research services, for USD 17.4 billion. This acquisition is expected to enhance Thermo Fisher's capabilities in the biopharmaceutical services industry and expand its single-use bioprocessing portfolio.
Sartorius AG has been actively expanding its single-use bioprocessing business through strategic acquisitions. In 2020, the company acquired the Slovenian purification specialist BIA Separations and the US-based filtration expert WaterSep BioSeparations.
The market is also witnessing the entry of new players and the formation of strategic partnerships to develop innovative single-use bioprocessing solutions. In 2022, Avantor, Inc. and Cytiva (formerly GE Healthcare Life Sciences) entered into a strategic collaboration to provide end-to-end single-use solutions for the biopharmaceutical industry.
The Single use Bioprocessing Market is poised for significant growth in the coming years, driven by the increasing demand for biopharmaceuticals and the advantages offered by single-use technologies. The COVID-19 pandemic has further accelerated the adoption of single-use bioprocessing, as it enables faster and more flexible production of vaccines and therapeutics.
The market is expected to witness continued innovation and advancements in single-use technologies, with a focus on improving the performance, scalability, and sustainability of these systems. The development of novel materials, sensors, and automation technologies will play a crucial role in shaping the future of the Single use Bioprocessing industry.
As the market continues to grow, there will be an increasing emphasis on addressing the challenges associated with single-use bioprocessing, such as supply chain management, standardization, and environmental impact. Collaborations between industry stakeholders, regulatory bodies, and academia will be essential to overcome these challenges and ensure the sustainable growth of the Single use Bioprocessing Market.
Thermo Fisher Scientific
Sartorius AG
Danaher Corporation
Merck KGaA
GE Healthcare
Avantor, Inc.
Pall Corporation
Saint-Gobain
Repligen Corporation
Eppendorf AG
In January 2024, Thermo Fisher Scientific launched a new single-use bioreactor system with advanced process control capabilities.
In November 2023, Sartorius AG expanded its single-use bioprocessing facility in Puerto Rico to meet the growing demand for single-use technologies in the region.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (KEY COMPANIES LIST BY COUNTRY) (PREMIUM)*
5. COMPANY PROFILES
5.1. Thermo Fisher Scientific
5.2. Sartorius AG
5.3. Danaher Corporation
5.4. Merck KGaA
5.5. GE Healthcare
5.6. Avantor, Inc.
5.7. Pall Corporation
5.8. Saint-Gobain
5.9. Repligen Corporation
5.10. Eppendorf AG (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Growing Demand for Biopharmaceuticals
6.1.2. Trend 2
6.1.3. Trend 3
6.2. Market Drivers
6.2.1. Advantages of Single-use Systems
6.2.2. Driver 2
6.2.3. Driver 3
6.3. Market Restraints
6.3.1. Technological Advancements
6.3.2. Restraint 2
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Single-use Bioreactors
7.2. Membrane Adsorbers
7.3. Mixing Systems
7.4. Tangential Flow Filtration Devices
7.5. Tubing and Connectors
7.6. Sampling Systems
8. BY WORKFLOW (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Upstream
8.2. Fermentation
8.3. Downstream
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Biopharmaceutical Manufacturers
9.2. Contract Manufacturing Organizations
9.3. Academic & Research Institutes
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
By Product:
Single-use Bioreactors
Membrane Adsorbers
Mixing Systems
Tangential Flow Filtration Devices
Tubing and Connectors
Sampling Systems
By Workflow:
Upstream
Fermentation
Downstream
By End User:
Biopharmaceutical Manufacturers
Contract Manufacturing Organizations
Academic & Research Institutes
By Region:
North America
Europe
Asia-Pacific
Latin America
Middle East
Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511
